Showing results (21-30 of 280) with videos related to
Sort By:
Pageof 28
Leukemia & Lymphoma|August 28, 2010
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylationElizabeth A Griffiths, Steven D Gore, Craig Hooker, et al.Cancer Control : Journal of the Moffitt Cancer Center|December 17, 2009
Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromesSteven D Gore, Evelyn R Hermes-DeSantisCancer Control : Journal of the Moffitt Cancer Center|October 18, 2008
Future directions in myelodysplastic syndrome: newer agents and the role of combination approachesSteven D Gore, Evelyn R Hermes-DeSantisBlood Reviews|August 20, 2013
Current therapy of myelodysplastic syndromesAmer M Zeidan, Yuliya Linhares, Steven D GoreExpert Review of Hematology|September 3, 2013
Iron chelation therapy in myelodysplastic syndromes: where do we stand?Mhairi Mitchell, Steven D Gore, Amer M ZeidanCancer Journal (Sudbury, Mass.)|April 28, 2007
DNA demethylating agents and histone deacetylase inhibitors in hematologic malignanciesTamer E Fandy, Hetty Carraway, Steven D GoreBlood Reviews|April 1, 2018
To chelate or not to chelate in MDS: That is the question!Amer M Zeidan, Elizabeth A GriffithsLeukemia & Lymphoma|January 21, 2003
Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemiaMuhammad Wasif Saif, Jon L Hopkins, Steven D GoreSeminars in Hematology|June 27, 2015
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future DirectionsTae Kon Kim, Steven D Gore, Amer M ZeidanCurrent Opinion in Hematology|February 24, 2010
Novel approaches for myelodysplastic syndromes: beyond hypomethylating agentsArturo Loaiza-Bonilla, Steven D Gore, Hetty E CarrawayPageof 28